Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis. This study mainly prospectively analyze the clinical data of patients with chronic liver disease related acute liver failure admitted to the department of infectious diseases, Xiangya Hospital of Central South University, to analyze the prognosis of patients with chronic liver disease related acute on-chronic liver failure in Central South China. No additional interventions other than routine treatment will be added.
Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis and would help determine in whom the treatment is effective. This study mainly prospectively analyze the clinical data of patients with chronic liver disease related acute liver failure admitted to the department of infectious diseases, Xiangya Hospital of Central South University, to analyze the short-time and relatively long-term prognosis of patients with chronic liver disease related acute on-chronic liver failure. This is an observational study. All subjects will receive the currently recognized routine treatment of liver failure and corresponding etiological treatment if needed. The researchers will collect various clinical examination indexes of the subjects in the process of diagnosis and treatment, including but not limited to blood routine, biochemistry, coagulation function, liver imaging, therapeutic drugs, etc. Complications and prognosis of patients will be recorded. Blood samples, urine and stool samples of all subjects will be taken after enrollment and stored for probably testing in the future. This study has no additional intervention and treatment for subjects. All subjects will sign informed consent.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| patients with acute on chronic liver failure | All subjects will receive the currently routine treatment of liver failure and corresponding etiological treatment if needed. The researchers will collect various clinical examination results of the subjects in the process of diagnosis and treatment, including but not limited to blood routine, biochemistry, coagulation function, liver imaging, therapeutic drugs, etc. Complications and prognosis of patients will be recorded. Blood samples, urine and stool samples of all subjects will be collected after enrollment and stored for probably testing in the future. This study has no additional intervention and treatment for subjects. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Non-liver transplant mortality | short time mortality | 15 days |
| Non-liver transplant mortality | short time mortality | 30 days |
| Non-liver transplant mortality | short time mortality | 90 days |
| Non-liver transplant mortality | long time mortality | 12 months |
| Non-liver transplant mortality | long time mortality | 36 months |
| Measure | Description | Time Frame |
|---|---|---|
| Liver transplantation rate | mortality of all patients including those receiving liver transplantation | 1 month |
| Liver transplantation rate | mortality of all patients including those receiving liver transplantation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patient with any cause of chronic liver disease who underwent acute liver dysfunction meets the criteria of ACLF of APASL.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yan Huang, Professor | Contact | 13874854142 | drhyan@163.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Xiangya Hospital | Recruiting | Changsha | Hunan | 410000 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D065290 | Acute-On-Chronic Liver Failure |
| ID | Term |
|---|---|
| D017114 | Liver Failure, Acute |
| D017093 | Liver Failure |
| D048550 | Hepatic Insufficiency |
| D008107 | Liver Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
whole blood includes blood cells and serum, urine and fecal samples
| 6 months |
| Liver transplantation rate | mortality of all patients including those receiving liver transplantation | 12 months |
| Model for disease severity | MELD score will be calculated and reported | 1 month |
| Model for disease severity | MELD score will be calculated and reported | 6 months |
| Model for disease severity | MELD score will be calculated and reported | 12 months |
| D004066 |
| Digestive System Diseases |